<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>132(8)</volume><submitter>Nair M</submitter><funding>British Heart Foundation</funding><funding>Medical Research Council</funding><funding>National Institute for Health and Care Research Applied Research Collaboration Oxford and Thames Valley</funding><pubmed_abstract>&lt;h4>Objective&lt;/h4>Assessment of whether maternal anaemia in early pregnancy is associated with offspring congenital heart disease (CHD).&lt;h4>Design&lt;/h4>Matched case-control study.&lt;h4>Setting&lt;/h4>January 1998-October 2020, United Kingdom.&lt;h4>Population&lt;/h4>Women with a haemoglobin measurement in the first 100 days of pregnancy and a CHD-diagnosed child.&lt;h4>Methods&lt;/h4>Data were extracted from the United Kingdom Clinical Practice Research Datalink GOLD database of electronic health records. Cases were 2,776 women with a CHD-diagnosed child. These were compared to 13 880 matched controls, women without a CHD-diagnosed child. Anaemia was classified as &lt; 110 g/L haemoglobin following the WHO definition. A conditional logistic regression analysis was conducted, adjusted for potential maternal demographic and health-related confounders.&lt;h4>Main outcome measures&lt;/h4>Offspring CHD diagnosed within 5 years of birth.&lt;h4>Results&lt;/h4>123 (4.4%) cases and 390 (2.8%) controls had anaemia. After adjusting for potential confounders, the odds of giving birth to a CHD-diagnosed child were 47% higher among anaemic mothers (adjusted OR 1.47, 95% CI 1.18,1.83, p &lt; 0.001).&lt;h4>Conclusions&lt;/h4>The observed association between maternal anaemia in early pregnancy and increased risk of offspring CHD supports our recent evidence in mice. Approximately two-thirds of anaemia cases globally are due to iron deficiency. A clinical trial of periconceptional iron supplementation might be a minimally invasive and low-cost intervention for the prevention of some CHD if iron deficiency anaemia is proven to be a cause.</pubmed_abstract><journal>BJOG : an international journal of obstetrics and gynaecology</journal><pagination>1139-1146</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12137751</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Maternal Anaemia and Congenital Heart Disease in Offspring: A Case-Control Study Using Linked Electronic Health Records in the United Kingdom.</pubmed_title><pmcid>PMC12137751</pmcid><pubmed_authors>Sparrow DB</pubmed_authors><pubmed_authors>Smith M</pubmed_authors><pubmed_authors>Bankhead CR</pubmed_authors><pubmed_authors>Nair M</pubmed_authors><pubmed_authors>Drakesmith CW</pubmed_authors></additional><is_claimable>false</is_claimable><name>Maternal Anaemia and Congenital Heart Disease in Offspring: A Case-Control Study Using Linked Electronic Health Records in the United Kingdom.</name><description>&lt;h4>Objective&lt;/h4>Assessment of whether maternal anaemia in early pregnancy is associated with offspring congenital heart disease (CHD).&lt;h4>Design&lt;/h4>Matched case-control study.&lt;h4>Setting&lt;/h4>January 1998-October 2020, United Kingdom.&lt;h4>Population&lt;/h4>Women with a haemoglobin measurement in the first 100 days of pregnancy and a CHD-diagnosed child.&lt;h4>Methods&lt;/h4>Data were extracted from the United Kingdom Clinical Practice Research Datalink GOLD database of electronic health records. Cases were 2,776 women with a CHD-diagnosed child. These were compared to 13 880 matched controls, women without a CHD-diagnosed child. Anaemia was classified as &lt; 110 g/L haemoglobin following the WHO definition. A conditional logistic regression analysis was conducted, adjusted for potential maternal demographic and health-related confounders.&lt;h4>Main outcome measures&lt;/h4>Offspring CHD diagnosed within 5 years of birth.&lt;h4>Results&lt;/h4>123 (4.4%) cases and 390 (2.8%) controls had anaemia. After adjusting for potential confounders, the odds of giving birth to a CHD-diagnosed child were 47% higher among anaemic mothers (adjusted OR 1.47, 95% CI 1.18,1.83, p &lt; 0.001).&lt;h4>Conclusions&lt;/h4>The observed association between maternal anaemia in early pregnancy and increased risk of offspring CHD supports our recent evidence in mice. Approximately two-thirds of anaemia cases globally are due to iron deficiency. A clinical trial of periconceptional iron supplementation might be a minimally invasive and low-cost intervention for the prevention of some CHD if iron deficiency anaemia is proven to be a cause.</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Jul</publication><modification>2026-05-29T16:32:53.278Z</modification><creation>2025-07-26T03:06:33.125Z</creation></dates><accession>S-EPMC12137751</accession><cross_references><pubmed>40264354</pubmed><doi>10.1111/1471-0528.18150</doi></cross_references></HashMap>